ArticleInternational journal of dentistry2025
Comparing the Knowledge and Awareness of Dental Students, Dental Practitioners and Patients About Botulinum Toxin and Its Therapeutic Applications in Temporomandibular Disorders.
Article in International journal of dentistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aims to assess the awareness of botulinum toxin (BTX), a treatment for temporomandibular disorders (TMDs) and bruxism, among patients, dental students and dental practitioners. Methods: Over a 7-month period (September 2023-March 2024), a paper-based questionnaire was distributed to randomly selected patients, dental students, and practitioners at the Griffith University Dental Clinic (GUDC) in Queensland, Australia. The questionnaire assessed participants' knowledge and awareness of BTX as a treatment for TMD and bruxism. Results: A total of 325 participants completed the questionnaire, comprising 171 patients, 130 students and 24 dental practitioners. Dental practitioners demonstrated the highest knowledge and awareness surrounding the uses of BTX in TMD treatment. While students had less knowledge than practitioners, their understanding of BTX increased as they advanced through their studies. Both dental practitioners and students favored non-BTX treatments for TMD. Patients exhibited limited awareness of BTX, with female patients being more informed and receptive. Conclusion: The results from this study highlight the need for increased awareness of BTX for the treatment of TMD, particularly amongst patients and dental students, and to a lesser extent, dental practitioners.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.